Interestingly, EPPK1 exhibited no marked differences in mRNA expression between AD and controls, with a slight increase observed in AD, contrasting with the significant downregulation as seen in psoriatic lesions (Figure 4H). This evidence concerns the gene EPPK1 and Alzheimer disease.